91 related articles for article (PubMed ID: 2199426)
1. Gemfibrozil in dyslipidaemia.
Kundu SC; Roxy S; Batabyal SK
J Assoc Physicians India; 1990 Feb; 38(2):156-9. PubMed ID: 2199426
[TBL] [Abstract][Full Text] [Related]
2. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
Varthakavi PK; Turakhia DP; Sharma SS; Salgaonkar DS; Nihalani KD; Joshi VR
J Assoc Physicians India; 1990 Feb; 38(2):136-40. PubMed ID: 2380132
[TBL] [Abstract][Full Text] [Related]
3. [Multicenter clinical, double blind, and randomized study to assess the effectiveness and safety of binifibrate versus gemfibrozil in type IIa, IIb, and IV hyperlipidemia].
Corominas Vilardell A; de Oya Otero M; Escobar Jiménez F; Anguera Vila A; Ariño Armengol B
An Med Interna; 1993 Nov; 10(11):537-41. PubMed ID: 8117868
[TBL] [Abstract][Full Text] [Related]
4. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil.
Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A
Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163
[TBL] [Abstract][Full Text] [Related]
5. [Gemfibrozil in the treatment of lipid metabolism disorders].
Vartanova OA; Aleksandrovskaia TN; Shaldaeva VV
Klin Med (Mosk); 1994; 72(1):37-41. PubMed ID: 8196321
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
Wolf HR
Drugs Exp Clin Res; 1994; 20(3):109-13. PubMed ID: 7956717
[TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil in CAPD patients.
De Vecchi A; Scalamogna A; Pini C; Castelnovo C; Colombini M; Lepore R
Adv Perit Dial; 1991; 7():240-2. PubMed ID: 1680435
[TBL] [Abstract][Full Text] [Related]
8. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
[TBL] [Abstract][Full Text] [Related]
9. Effects of gemfibrozil on plasma lipoprotein-apolipoprotein distribution and platelet reactivity in patients with hypertriglyceridemia.
Sirtori CR; Franceschini G; Gianfranceschi G; Sirtori M; Montanari G; Tremoli E; Maderna P; Colli S; Zoppi F
J Lab Clin Med; 1987 Sep; 110(3):279-86. PubMed ID: 3475394
[TBL] [Abstract][Full Text] [Related]
10. [Simvastatin versus gemfibrozil in the treatment of primary hypercholesterolemia in hypertensive patients treated with hydrochlorothiazide].
Berioli S; Bentivoglio M; Conti R; Osanna RA; Savino K; Zollino L; Corea L
Cardiologia; 1990 Apr; 35(4):335-40. PubMed ID: 2245435
[TBL] [Abstract][Full Text] [Related]
11. [Gemfibrozil in the treatment of hyperlipidemia].
Wang JJ; Song YM; Wang YS; Lin WH
Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):131-4. PubMed ID: 2766068
[TBL] [Abstract][Full Text] [Related]
12. The effect of simvastatin on HDL cholesterol in hyperlipidemic patients. Evidence of a relationship with the changes in serum triglyceride level.
Branchi A; Rovellini A; Fiorenza AM; Maraffi F; Gandini R; Sommariva D
Int J Clin Pharmacol Ther; 1996 Sep; 34(9):384-9. PubMed ID: 8880287
[TBL] [Abstract][Full Text] [Related]
13. [Different effects of fibrates on the lipoprotein profile. Comparison of the effectiveness of gemfibrozil and bezafibrate in various types of hyperlipoproteinemia].
Julius U; Hora C; Gross P; Fücker K; Bergmann S; Hanefeld M
Fortschr Med; 1992 Dec; 110(35-36):669-72. PubMed ID: 1487226
[TBL] [Abstract][Full Text] [Related]
14. Gemfibrozil treatment increases low-density lipoprotein particle size in Type 2 diabetes mellitus but does not alter in vitro oxidizability.
O'Neal DN; O'Brien RC; Timmins KL; Grieve GD; Lau KP; Nicholson GC; Kotowicz MA; Best JD
Diabet Med; 1998 Oct; 15(10):870-7. PubMed ID: 9796889
[TBL] [Abstract][Full Text] [Related]
15. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
[TBL] [Abstract][Full Text] [Related]
16. [A long-term study on blood lipids after gemfibrozil].
Lu Z
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):369-71. PubMed ID: 1821353
[No Abstract] [Full Text] [Related]
17. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
Büyükçelik M; Anarat A; Bayazit AK; Noyan A; Ozel A; Anarat R; Aydingülü H; Dikmen N
Turk J Pediatr; 2002; 44(1):40-4. PubMed ID: 11858378
[TBL] [Abstract][Full Text] [Related]
18. Long-term effect of gemfibrozil on coronary heart disease risk profile of patients with primary combined hyperlipidaemia.
Athyros VG; Papageorgiou AA; Avramidis MJ; Kontopoulos AG
Coron Artery Dis; 1995 Mar; 6(3):251-6. PubMed ID: 7788039
[TBL] [Abstract][Full Text] [Related]
19. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
[TBL] [Abstract][Full Text] [Related]
20. Management of primary mixed hyperlipidemia with lovastatin.
Vega GL; Grundy SM
Arch Intern Med; 1990 Jun; 150(6):1313-9. PubMed ID: 2353864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]